| |
|
|
|
Rigel Pharmaceuticals Inc.  
|
|
2.34 0.11 (0.05%) |
06-18 16:00 |
|
Open: |
2.23 |
Pre close: |
2.23 |
Target:
|
2.76 
|
|
High: |
2.36 |
Low: |
2.22 |
Resistance:
|
2.36
2.76
|
|
Volume: |
1,206,661 |
Market Cap: |
391M |
Support:
|
2.13
1.98
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.16
|
MACD |
MACD(12,26):
|
-0.01 |
|
MA(20): |
2.12 |
Signal(12,26,9): |
-0.04 |
|
MA(100): |
2.28 |
Stochastic Oscillator |
%K(14,3):
|
68.66 |
|
MA(250): |
2.62  |
%D(3): |
51.73 |
|
Average Volume(K) |
3-Month: |
147403
|
52-Week |
High:
|
3.65 |
|
10-Days: |
115601 |
Low: |
1.96 |
|
RSI |
RSI(14):
|
61.12 |
Change(%): |
-25.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.450 |
Return on Equity (ttm) |
-75.8 |
Shares Out. (M) |
167.19 |
|
EPS Est. Current Year |
-0.600 |
Return on Assets (ttm) |
-48.5 |
Shares Float (M) |
166.52 |
|
EPS Est. Next Year |
-0.430 |
PEG Ratio |
-0.08 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.150 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
0.00 |
|
Forward EPS |
-0.470 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
3.560 |
EBITDA (p.s.) |
0.000 |
P/E |
-5.20 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.66 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-36.00 |
P/S |
1150660608.00 |
|
Operating Margin |
-116.09 |
Levered Free Cash Flow
(M) |
-41.46 |
P/CF |
-10.87 |
|
|
|
|
|
|
